In vitro antimicrobial activity, total polyphenols and flavonoids contents of Nopalea cochenillifera (L.) Salm-Dyck (Cactaceae)

This study evaluated the antimicrobial activity in vitro qualitative and quantitative methods, and made the determination of total polyphenols and flavonoids in the ethanol extract of Nopalea cochenillifera. The assessment determined the antimicrobial minimum inhibitory concentration (MIC) against Escherichia coli, Salmonella typhi, Micrococcus, Klebsiella pneumoniae, Staphylococcus aureus, Candida albicans, Candida glabrata, Prototheca zopffi, Cryptococcus neoformans, Saccharomyces cervisiae e Malassezia furfur. The determination of total polyphenols and flavonoids were significant when compared respectively to the standards of gallic acid and rutin

Immunotherapy for Fungal Infections

Opportunistic fungal infections are a major health problem being appointed by some studies as the fourth main cause of hospital-acquired infection in susceptible populations. The constantly growing incidences of these diseases are associated with the growing number of susceptible individuals, such as immunocompromised individuals (leukemia, AIDS, etc) and treatment-induced immunodeficiency (hematopoietic stem cell, solid organ transplant, anticancer therapy). Furthermore, other advances in medical care, patient’s long-term hospitalization and antimicrobial therapies have created several vulnerable populations to fungal infections. Currently, antifungal drug therapies are several times inefficient, and the poor outcomes are linked to difficulties in the early diagnosis of fungal infections and drug resistance among fungal pathogens. In this context, novel therapeutic approaches are welcome to stimulate efficiently the host immune response to eliminate the fungal pathogen. This chapter is intended to review advances in immunotherapy strategies for fungal infections

In vitro inhibition of the bovine viral diarrhoea virus by the essential oil of Ocimum basilicum (basil) and monoterpenes

The bovine viral diarrhoea virus (BVDV) is suggested as a model for antiviral studies of the hepatitis C virus (HCV). The antiviral activity of the essential oil of Ocimum basilicum and the monoterpenes camphor, thymol and 1,8-cineole against BVDV was investigated. The cytotoxicities of the compounds were measured by the MTT (3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide) test, and the antiviral activities were tested by the plaque reduction assay. The oil or compounds were added to the assay in three different time points: a) pre-treatment of the virus (virucidal assay); b) pre-treatment of the cells; or c) post-treatment of the cells (after virus inoculation). The percentage of plaques inhibition for each compound was determined based on the number of plaques in the viral control. The results were expressed by CC50 (50% cytotoxic concentration), IC50 (inhibitory concentration for 50% of plaques) and SI (selectivity index = CC50/IC50). Camphor (CC50 = 4420.12 µgmL-1) and 1,8-cineole (CC50 = 2996.10 µgmL-1) showed the lowest cytotoxicities and the best antiviral activities (camphor SI = 13.88 and 1,8-cineol SI = 9.05) in the virucidal assay. The higher activities achieved by the monoterpenes in the virucidal assay suggest that these compounds act directly on the viral particle

Identificação de Candida dubliniensis isoladas no Brasil, através do método comercial ID 32C

The purpose of the present study was to evaluate the identification of 19 Brazilian C. dubliniensis based on the biochemical profile exhibited when tested by the commercial identification kit ID 32C (bioMerieux). Thirteen of the isolates were rigorously identified as C. dubliniensis and the remaining isolates (six) were considered as having a doubtful profile but the software also suggested that there was 83.6% of chances for them to be C. dubliniensis. As well as pointed by the literature the identification obtained by phenotypic tests should be considered presumptive for C. dubliniensis due to variability of this new species.Dezenove culturas de C. dubliniensis isoladas no Brasil, previamente identificadas através de métodos genotípicos, foram avaliadas pelo kit comercial ID 32C (bioMerieux). Treze culturas foram identificadas como C. dubliniensis, mas as demais (seis) evidenciaram perfil duvidoso, embora o software do sistema sugerisse 83,6% de chances das mesmas pertencerem à espécie C. dubliniensis. A literatura tem registrado grande variabilidade fenotípica com esta espécie e, por isto, as identificações obtidas com este sistema deverão ser consideradas como presuntivas.Universidade Federal de Santa Maria Centro de Ciências da Saúde Departamento de Microbiologia e ParasitologiaUniversidade Federal do Rio Grande do SulUniversidade Federal do Rio Grande do NorteUniversidade Federal de São Paulo (UNIFESP)UNIFESPSciEL

Carbohydrate assimilation profiles of Brazilian Candida dubliniensis isolates based on ID 32C system

The purpose of the present study was to evaluate the identification of 19 Brazilian C. dubliniensis based on the biochemical profile exhibited when tested by the commercial identification kit ID 32C (bioMerieux). Thirteen of the isolates were rigorously identified as C. dubliniensis and the remaining isolates (six) were considered as having a doubtful profile but the software also suggested that there was 83.6% of chances for them to be C. dubliniensis. As well as pointed by the literature the identification obtained by phenotypic tests should be considered presumptive for C. dubliniensis due to variability of this new species.Dezenove culturas de C. dubliniensis isoladas no Brasil, previamente identificadas através de métodos genotípicos, foram avaliadas pelo kit comercial ID 32C (bioMerieux). Treze culturas foram identificadas como C. dubliniensis, mas as demais (seis) evidenciaram perfil duvidoso, embora o software do sistema sugerisse 83,6% de chances das mesmas pertencerem à espécie C. dubliniensis. A literatura tem registrado grande variabilidade fenotípica com esta espécie e, por isto, as identificações obtidas com este sistema deverão ser consideradas como presuntivas

Antimicrobial Activity of a Crude Extract and Fractions from Alternanthera brasiliana (L.) O. Kuntze Leaves

SUMMARY. Aqueous EtOH (70%) crude extract of Alternanthera brasiliana leaves and dichloromethane, ethyl acetate and butanolic fractions of the crude extract were tested against a panel of microrganisms by the broth microdilution method to determine the Minimal Inhibitory Concentration (MIC). The results demonstrate that the crude extract and some fractions showed moderate activities against Staphylococcus aureus, Pseudomonas aeruginosa, Saccharomyces cerevisae and Prototheca zopffi. All samples did not present activity against the bacteria Escherichia coli, Candida albicans and Candida glabrata. The strongest effect occurred with dichloromethane fraction against the algae P. zopfii, (MIC= 312.5 μg.mL -1 ). These results demonstrate that A. brasiliana have a weak antimicrobial activity that not support the ethno-pharmacological indication of the plant for the treatment of infection diseases nor it's popular names such as "penicillin" and "terramycin" in Brazil . RESUMEN. "Actividad Antimicrobiana del Extracto Bruto y Fracciones de las Hojas de Alternanthera brasiliana (L.) O. Kuntze". El extracto etanólico crudo (70%) y las fracciones diclorometánica, de acetato de etilo y butanólica de las hojas de A. brasiliana fueron analizados en relación a su actividad antimicrobiana. Las concentraciones inhibitorias mínimas (MIC) fueron determinadas usando el método de microdilución en caldo. Los experimentos demostraron que el extracto y algunas fracciones exhibieron moderada acción antimicrobiana, particularmente contra Staphylococcus aureus, Pseudomonas aeruginosa, Saccharomyces cerevisae y Prototheca zopffi. El efecto más fuerte ocurrió con la fracción diclorometánica frente a P. zopfii (MIC 312,5 μg.mL -1 ). La bacteria Escherichia coli y las leveduras Candida albicans y C. glabrata no fueron inhibidas por ninguno de los extractos probados. La baja actividad antimicrobiana de la planta no respalda las indicaciones planteadas por la comunidad para su uso en el tratamiento de procesos infecciosos, ni tampoco sus nombres populares en Brasil, tales como "penicilina" y "terramicina"

Rotation of planet-harbouring stars

The rotation rate of a star has important implications for the detectability, characterisation and stability of any planets that may be orbiting it. This chapter gives a brief overview of stellar rotation before describing the methods used to measure the rotation periods of planet host stars, the factors affecting the evolution of a star's rotation rate, stellar age estimates based on rotation, and an overview of the observed trends in the rotation properties of stars with planets.Comment: 16 pages, 4 figures: Invited review to appear in 'Handbook of Exoplanets', Springer Reference Works, edited by Hans J. Deeg and Juan Antonio Belmont

Antimicrobials: A Global Alliance For Optimizing Their Rational Use In Intra-abdominal Infections (agora)

Intra-abdominal infections (IAI) are an important cause of morbidity and are frequently associated with poor prognosis, particularly in high-risk patients. The cornerstones in the management of complicated IAIs are timely effective source control with appropriate antimicrobial therapy. Empiric antimicrobial therapy is important in the management of intra-abdominal infections and must be broad enough to cover all likely organisms because inappropriate initial antimicrobial therapy is associated with poor patient outcomes and the development of bacterial resistance. The overuse of antimicrobials is widely accepted as a major driver of some emerging infections (such as C. difficile), the selection of resistant pathogens in individual patients, and for the continued development of antimicrobial resistance globally. The growing emergence of multi-drug resistant organisms and the limited development of new agents available to counteract them have caused an impending crisis with alarming implications, especially with regards to Gram-negative bacteria. An international task force from 79 different countries has joined this project by sharing a document on the rational use of antimicrobials for patients with IAIs. The project has been termed AGORA (Antimicrobials: A Global Alliance for Optimizing their Rational Use in Intra-Abdominal Infections). The authors hope that AGORA, involving many of the world's leading experts, can actively raise awareness in health workers and can improve prescribing behavior in treating IAIs.11NIAID NIH HHS [R01 AI117211